The average one-year price target for Milestone Pharmaceuticals (NasdaqGS:MIST) has been revised to $6.73 / share. This is an ...

It has been almost a year since Facebook announced its blockbuster acquisition of messaging start-up, WhatsApp. All the while, I've remained a bit skeptical over the hefty $22 billionprice tag, ...

Milestone Partners, a buyout firm based in Saint Davids, Penn., has closed on capital commitments totaling $230 million for its third fund. It had a target of $200 million. Milestone Partners ...

Investing.com -- TD Securities downgraded Milestone Pharmaceuticals (NASDAQ:MIST) to "Hold" and suspended its price target, citing regulatory uncertainty and commercialization challenges for its lead ...

Milestone’s commercial strategy includes deploying 60 representatives who will target between 10,000 and 15,000 high-volume prescribers, according to Jefferies’ research. The firm indicated that ...

Wells Fargo analyst Mohit Bansal raised the firm’s price target on Milestone Pharmaceuticals (MIST) to $8 from $4 and keeps an Overweight rating ...

Target has entered a new frontier, a world of green long void of bullseye red: the state of Vermont. Vermont has long stood as the only state without a Target store, but that will change later this ...